Clinical Trial

A Novel Fluorescent Ductal Needle for Localization and Sampling of Micro Lesions in Breast Ducts

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated June 11, 2026 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
This prospective, multicenter cohort study investigates the differences in the reliability of rapid pathology compared to postoperative pathology when utilizing a novel fluorescent localization needle equipped with a controllable shedding quantum dot chiral nanofluorescent coating, in contrast to traditional localization techniques for breast duct lesions. The principal objective is to assess the clinical efficacy of this innovative fluorescent localization needle in enabling precise pathological diagnosis of micro lesions in breast ducts.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2026-01-13; most recent amendment 2026-06-10.
Status change: Not Yet Recruiting → Recruiting 2026-01-23
Trial Details
NCT Number NCT07339306
Lead Sponsor The Fourth Affiliated Hospital of China Medical University
Conditions Mammary Tumor, Nipple Discharge, Breast Ductal Carcinoma In Situ
Enrollment 300 participants
Start Date 2026-01-01
Primary Completion 2026-06-30 (estimated)
Study Completion 2026-09-30 (estimated)
Updated on ClinicalTrials.gov 2026-06-11